TrialScience translational medicine2013

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.

Renier J Brentjens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.